Clover Health Investments

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLOV and other ETFs, options, and stocks.

About CLOV

Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. 

CEO
Andrew Toy
CEOAndrew Toy
Employees
724
Employees724
Headquarters
Wilmington, Delaware
HeadquartersWilmington, Delaware
Founded
2014
Founded2014
Employees
724
Employees724

CLOV Key Statistics

Market cap
1.03B
Market cap1.03B
Price-Earnings ratio
-12.03
Price-Earnings ratio-12.03
Dividend yield
Dividend yield
Average volume
5.75M
Average volume5.75M
High today
$2.04
High today$2.04
Low today
$1.93
Low today$1.93
Open price
$2.00
Open price$2.00
Volume
6.57M
Volume6.57M
52 Week high
$3.92
52 Week high$3.92
52 Week low
$1.93
52 Week low$1.93

Stock Snapshot

As of today, Clover Health Investments(CLOV) shares are valued at $2.00. The company's market cap stands at 1.03B, with a P/E ratio of -12.03.

On 2026-03-04, Clover Health Investments(CLOV) stock traded between a low of $1.93 and a high of $2.04. Shares are currently priced at $2.00, which is +3.6% above the low and -2.0% below the high.

The Clover Health Investments(CLOV)'s current trading volume is 6.57M, compared to an average daily volume of 5.75M.

During the past year, Clover Health Investments(CLOV) stock moved between $1.93 at its lowest and $3.92 at its peak.

During the past year, Clover Health Investments(CLOV) stock moved between $1.93 at its lowest and $3.92 at its peak.

CLOV News

Simply Wall St 3d
Clover Health Profit Milestone Raises Questions About 2026 Earnings Outlook

Clover Health Investments reached full year adjusted EBITDA profitability in 2025. Management now projects the company could achieve its first GAAP net income...

Clover Health Profit Milestone Raises Questions About 2026 Earnings Outlook
TipRanks 5d
Clover Health price target lowered to $2.75 from $3 at UBS

UBS analyst Jonathan Yong lowered the firm’s price target on Clover Health (CLOV) to $2.75 from $3 and keeps a Neutral rating on the shares. Published first on...

Simply Wall St 5d
Assessing Whether Clover Health Investments Looks Undervalued After Recent Shareholder Return Weakness

Advertisement Recent performance snapshot for Clover Health Investments (CLOV) Clover Health Investments (CLOV) has seen mixed recent performance, with a 2.9%...

Assessing Whether Clover Health Investments Looks Undervalued After Recent Shareholder Return Weakness

More CLOV News

The Motley Fool 5d
Clover Health Q4 2025 Earnings Transcript

Image source: The Motley Fool. Thursday, February 26, 2026 at 5 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Andrew Toy Chief Financial Officer — Peter...

Clover Health Q4 2025 Earnings Transcript

People also own

Based on the portfolios of people who own CLOV. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.